PUMA BIOTECHNOLOGY, INC. — Form D/A
PUMA BIOTECHNOLOGY, INC. of LOS ANGELES, CA, a company, filed a Form D amendment with the SEC on 2011-10-12. The offering totals $55.0M, of which $55.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-10-12
- Form: D/A
- Accession: 0001531754-11-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $55.0M
- Amount sold: $55.0M
- Investors: 27
- Date of first sale: 2011-10-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-166750
Issuer
- Name: PUMA BIOTECHNOLOGY, INC.
- CIK: 0001531754
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 10940 WILSHIRE BLVD., LOS ANGELES, CA, 90024
- Phone: (310) 443-4150
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| ALAN H AUERBACH | Director | LOS ANGELES, CA |
| THOMAS R MALLEY | Director | HAMILTON, D0 |
| ALAN H AUERBACH | Executive Officer | LOS ANGELES, CA |
| CHARLES R EYLER | Executive Officer | LOS ANGELES, CA |
Other filings by this issuer (2)
More